UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82

Čájet eará veršuvnnaid (1)

Aims/hypothesis: The aim of this project was to build a new version of the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS-OM1), a patient-level simulation tool for predicting lifetime health outcomes of people with type 2 diabetes mellitus. Methods: Data from 5,102 UKPDS pat...

Bibliográfalaš dieđut
Váldodahkkit:	Hayes, A, Leal, J, Gray, A, Holman, R, Clarke, P
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Dahkki: Hayes, A, et al.
Almmustuhtton: (2013)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2004)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
Dahkki: Leal, J, et al.
Almmustuhtton: (2021)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Dahkki: Alva, M, et al.
Almmustuhtton: (2014)

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
Dahkki: Leal, J, et al.
Almmustuhtton: (2013)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Dahkki: Cull, C, et al.
Almmustuhtton: (2001)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Dahkki: Kohner, E, et al.
Almmustuhtton: (2001)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
Dahkki: Coleman, RL, et al.
Almmustuhtton: (2019)

Ethnic differences in diabetic nephropathy - The UKPDS
Dahkki: Stevens, R, et al.
Almmustuhtton: (1999)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Dahkki: Adler, A, et al.
Almmustuhtton: (2003)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Dahkki: Cull, C, et al.
Almmustuhtton: (2004)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2003)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Dahkki: Holman, R, et al.
Almmustuhtton: (2001)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Dahkki: Davis, T, et al.
Almmustuhtton: (1999)

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Dahkki: Keng, MJ, et al.
Almmustuhtton: (2021)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2005)

UKPDS: what was the question? UK Prospective Diabetes Study.
Dahkki: Turner, R, et al.
Almmustuhtton: (1999)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
Dahkki: Rury Holman
Almmustuhtton: (2022-09-01)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Dahkki: Gray, A, et al.
Almmustuhtton: (2001)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Dahkki: Holman, R
Almmustuhtton: (2007)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Dahkki: Matthews, DR, et al.
Almmustuhtton: (1998)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Dahkki: Stevens, R, et al.
Almmustuhtton: (2001)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
Dahkki: Davis, T, et al.
Almmustuhtton: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
Dahkki: Davis, T, et al.
Almmustuhtton: (2014)

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2002)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Dahkki: Stevens, R, et al.
Almmustuhtton: (2002)

Risk factors for neuropathy in UKPDS
Dahkki: Stratton, I, et al.
Almmustuhtton: (2004)

Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?
Dahkki: Gray, A, et al.
Almmustuhtton: (2014)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Dahkki: Turner, R, et al.
Almmustuhtton: (1999)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Dahkki: Widjaja, A, et al.
Almmustuhtton: (1996)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Dahkki: Davis, T, et al.
Almmustuhtton: (2013)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
Dahkki: Stevens, R, et al.
Almmustuhtton: (2000)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
Dahkki: Adler, A, et al.
Almmustuhtton: (1999)

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).
Dahkki: Gray, A, et al.
Almmustuhtton: (2002)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
Dahkki: Matthews, DR
Almmustuhtton: (1999)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
Dahkki: Matthews, DR
Almmustuhtton: (1999)

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2005)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
Dahkki: Widjaja, A, et al.
Almmustuhtton: (1997)

An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
Dahkki: Hayes, A, et al.
Almmustuhtton: (2011)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2006)